Clinical and histologic findings after use of a novel combined retinol, tripeptide, and glaucine containing cream in the treatment of photo-aged skin

J Cosmet Dermatol. 2023 Oct;22(10):2765-2768. doi: 10.1111/jocd.15945. Epub 2023 Aug 16.

Abstract

Background: Neck skin is thinner and has a more delicate dermal layer than facial skin. The studied product was specifically formulated for the neck combining a hydrating delivery system with a trifunctional corrective technology composed of 0.2% pure retinol, 2.5% tripeptide concentrate, and 5.0% glaucine complex to help improvement in signs of aging.

Objectives: To evaluate cosmetic and histologic changes 3 months after treatment using immunostains for Type I collagen, Type III collagen, and glycosaminoglycan (GAGS). In addition, overall clinical improvement in photoaged skin was measured by both Griffith's photonumeric photoaging scale, photographic improvement, and questionnaires.

Methods: This study was an open-label, blinded clinical trial evaluating a combined retinol, tripeptide, and glaucine containing cream in the treatment of photo-aged skin. The study enrolled a total of 20 healthy male or female subjects, who applied the product for 3 months to their face and neck.

Results: Clinical as well histologic changes were consistent with improvement in all 20 subjects.

Conclusion: Use of a combined retinol, tripeptide, and glaucine containing cream led to both clinical and histologic improvement of phototoaging.

Keywords: hydrating delivery system; neck cream; retinol; tripeptide concentrate.

Publication types

  • Clinical Trial

MeSH terms

  • Aporphines*
  • Female
  • Humans
  • Male
  • Skin / diagnostic imaging
  • Skin Aging*
  • Skin Cream
  • Treatment Outcome
  • Vitamin A / therapeutic use

Substances

  • Aporphines
  • glaucine
  • Vitamin A